Stay updated on DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial

Sign up to get notified when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record for the DPX-Survivac and pembrolizumab study in diffuse large B-cell lymphoma is displayed, including study details and participant information, where an error page had appeared before.
    Difference
    71%
    Check dated 2026-11-08T14:08:04.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:34:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition notice that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence,” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:36:18.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T22:06:48.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:06:42.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record view with an access-denied screen. This indicates restricted or blocked access to the record rather than a change to the study data.
    Difference
    21%
    Check dated 2026-09-20T20:44:16.000Z thumbnail image

Stay in the know with updates to DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.